Cas no 16732-66-4 ((2-Bromophenyl)hydrazine)
(2-Bromophenyl)hydrazine Chemical and Physical Properties
Names and Identifiers
-
- (2-Bromophenyl)hydrazine
- 1-(2-Bromophenyl)hydrazine
- 2-Bromophenylhydrazine
- (2-Bromo-phenyl)-hydrazine
- (2-bromophenyl)hydrazinehydrochloride
- (2-Brom-phenyl)-hydrazin
- AC1Q26FA
- Bromophenylhydrazine
- Hydrazine,(2-bromophenyl)-
- NSC157601
- o-bromophenylhydrazine
- SureCN7351
- FT-0656447
- NSC 157601
- SCHEMBL7351
- 2-bromophenyl hydrazine
- DS-12450
- BB 0249757
- J-500674
- 1-(2-Bromophenyl)hydrazine #
- NCGC00340653-01
- A7519
- NSC-157601
- NS00025491
- AB01331833-02
- AKOS002680110
- Hydrazine, (2-bromophenyl)-
- Hydrazine, (2-bromophenyl)-, hydrochloride
- A810851
- EINECS 240-797-4
- 16732-66-4
- MFCD00044518
- ?2-bromophenylhydrazine
- DTXSID60168276
- ALBB-014120
- BBL012157
- STK731594
-
- MDL: MFCD00044518
- Inchi: 1S/C6H7BrN2/c7-5-3-1-2-4-6(5)9-8/h1-4,9H,8H2
- InChI Key: ZWMQVBSLMQSMDH-UHFFFAOYSA-N
- SMILES: BrC1C=CC=CC=1NN
Computed Properties
- Exact Mass: 185.97931
- Monoisotopic Mass: 185.979
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 9
- Rotatable Bond Count: 1
- Complexity: 87.1
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 1.9
- Topological Polar Surface Area: 38A^2
Experimental Properties
- Density: 1.666
- Boiling Point: 275.7°Cat760mmHg
- Flash Point: 120.5°C
- Refractive Index: 1.68
- PSA: 38.05
- LogP: 2.50800
(2-Bromophenyl)hydrazine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A250000099-250mg |
2-Bromophenylhydrazine |
16732-66-4 | 98% | 250mg |
659.60 USD | 2021-06-15 | |
| Alichem | A250000099-500mg |
2-Bromophenylhydrazine |
16732-66-4 | 98% | 500mg |
970.20 USD | 2021-06-15 | |
| Alichem | A250000099-1g |
2-Bromophenylhydrazine |
16732-66-4 | 98% | 1g |
1,853.50 USD | 2021-06-15 | |
| TRC | B623765-10mg |
(2-Bromophenyl)hydrazine |
16732-66-4 | 10mg |
$ 50.00 | 2022-06-07 | ||
| TRC | B623765-50mg |
(2-Bromophenyl)hydrazine |
16732-66-4 | 50mg |
$ 95.00 | 2022-06-07 | ||
| TRC | B623765-100mg |
(2-Bromophenyl)hydrazine |
16732-66-4 | 100mg |
$ 135.00 | 2022-06-07 | ||
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTL237-250mg |
Hydrazine, (2-bromophenyl)- |
16732-66-4 | 95% | 250mg |
¥132.0 | 2024-04-23 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTL237-1g |
Hydrazine, (2-bromophenyl)- |
16732-66-4 | 95% | 1g |
¥363.0 | 2024-04-23 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBTL237-5g |
Hydrazine, (2-bromophenyl)- |
16732-66-4 | 95% | 5g |
¥1281.0 | 2024-04-23 | |
| abcr | AB377336-1 g |
(2-Bromophenyl)hydrazine |
16732-66-4 | 1g |
€127.00 | 2023-04-25 |
(2-Bromophenyl)hydrazine Suppliers
(2-Bromophenyl)hydrazine Related Literature
-
Nithya Murugesh,Ramasamy Karvembu,Seenuvasan Vedachalam Org. Biomol. Chem. 2020 18 7884
-
Sung Moo Kim,Sung Yong Byeon,Seok-Ho Hwang,Jun Yeob Lee Chem. Commun. 2015 51 10672
-
Nattawut Sawengngen,Petrakis N. Chalikidi,Sara Araby,Frank Hampel,Peter Gmeiner,Olga V. Serdyuk Org. Biomol. Chem. 2019 17 4850
-
Chaoren Shen,Nikki Y. T. Man,Scott Stewart,Xiao-Feng Wu Org. Biomol. Chem. 2015 13 4422
-
5. Synthesis of 5- and 7-bromotryptophan and of [5-bromotryptophan9]-β-corticotrophin-(1–24)-tetracosapeptide, a highly potent corticotrophin analogueMark C. Allen,Derek E. Brundish,Roy Wade J. Chem. Soc. Perkin Trans. 1 1980 1928
Additional information on (2-Bromophenyl)hydrazine
Market Research and Analysis of (2-Bromophenyl)hydrazine in Chemical-Biomedical Fields
(2-Bromophenyl)hydrazine, identified by the CAS number 16732-66-4, is a significant compound in the chemical and biomedical industries. This compound is widely utilized as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and advanced materials. Its unique chemical properties make it a valuable component in research and development activities across multiple sectors.
The global demand for (2-Bromophenyl)hydrazine has been steadily increasing due to its critical role in drug discovery and development. It serves as a key precursor in the synthesis of anti-cancer agents, antibiotics, and other bioactive molecules. The growing emphasis on personalized medicine and the development of targeted therapies have further fueled the demand for this compound.
Market analysis reveals that the primary drivers for the growth of (2-Bromophenyl)hydrazine include advancements in synthetic chemistry, expanding applications in drug design, and increasing investments in research and development activities. Additionally, the compound's versatility across different chemical reactions has made it a preferred choice for researchers worldwide.
The supply chain for (2-Bromophenyl)hydrazine is influenced by factors such as production costs, raw material availability, and regulatory requirements. Key suppliers are located in regions with established chemical manufacturing capabilities, including Asia-Pacific countries like China and India. These regions are known for their competitive pricing and efficient production processes.
In terms of market trends, there is a noticeable shift toward sustainable and eco-friendly production methods. The adoption of green chemistry principles is expected to play a pivotal role in shaping the future of this compound's production. Furthermore, the increasing focus on quality control and regulatory compliance is driving innovation in manufacturing processes.
To meet the rising demand, industry players are investing heavily in expanding their production capacities and enhancing their R&D capabilities. Collaborations between academic institutions, pharmaceutical companies, and chemical manufacturers are also fostering advancements in the application of (2-Bromophenyl)hydrazine across diverse fields.
In conclusion, (2-Bromophenyl)hydrazine continues to be a vital component in the chemical-biomedical industry due to its versatility and wide-ranging applications. As research progresses and new therapeutic areas emerge, the demand for this compound is anticipated to grow further. Stakeholders must remain proactive in addressing market dynamics to capitalize on emerging opportunities while ensuring sustainable practices throughout the supply chain.
16732-66-4 ((2-Bromophenyl)hydrazine) Related Products
- 622-88-8((4-bromophenyl)hydrazine;hydrochloride)
- 50709-33-6(2-Bromophenylhydrazine hydrochloride)
- 589-21-9((4-Bromophenyl)hydrazine)
- 41931-18-4(p-BromophenylHydrazine)
- 40887-80-7((3-bromophenyl)hydrazine)
- 67156-57-4((2-Bromo-4-methyl-phenyl)-hydrazine)
- 19718-35-5(Hydrazine, 1,2-bis(2-bromophenyl)-)
- 214915-87-4((2,5-Dibromophenyl)hydrazine hydrochloride)
- 62672-26-8((2,5-Dibromophenyl)hydrazine)
- 52722-79-9((2,4,6-tribromophenyl)hydrazine)